PMA device
Stockert 70 Radiofrequency Ablation Generator
Biosense Webster, Inc. · Catheter, Electrode Recording, Or Probe, Electrode Recording (DRF, Class II) · First FDA decision Feb 15, 2002, newest Jun 6, 2005Atrial fibrillationVentricular arrhythmia and sudden cardiac arrest
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
PMA pathway
Device trials
1
Naming "Stockert 70 Radiofrequency"
MAUDE reports
0
Brand "Stockert 70 Radiofrequency", since 2015
PubMed studies
0
Mentioning "Stockert 70 Radiofrequency"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Stockert 70 Radiofrequency Ablation Generator
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- STOCKERT 70 RADIOFREQUENCY ABLATION GENERATORPMA supplement
P990071-S005 · Decided Jun 6, 2005 · 532 days after receipt · Normal 180 Day Track
Device type: CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING (DRF) · Cardiology
- STOCKERT 70 RADIOFREQUENCY ABLATION GENERATORPMA supplement
P990071-S002 · Decided Feb 15, 2002 · 78 days after receipt · Normal 180 Day Track
Device type: CATHETER, ELECTRODE RECORDING, OR PROBE, ELECTRODE RECORDING (DRF) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Stereotaxic Depth Electrode ImplantationNational determinationOn the books160.5Updated Apr 20, 2020
Clinical trials
Device studies on ClinicalTrials.gov that name "Stockert 70 Radiofrequency", any status and sponsor, newest update first.
Biosense Webster, Inc.Public (JNJ)
NCT00318565 · 291 participants · Start Jan 2006 · Primary completion Sep 2007
Device: RF energy delivery for treatment of Typical Atrial flutter · For: Atrial Flutter
Sites: Birmingham, Alabama; Scottsdale, Arizona; Los Angeles, California · 23 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Stockert 70 Radiofrequency", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code DRF
6,595 reports: 3,079 malfunction, 3,259 injury, 233 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0058-2018 · Started Sep 6, 2017
Reason given: Biosense Webster, Inc. has recently received an increased number of complaints related to the display of Alert 402 on the CARTO 3 System for certain lots of THERMOCOOL brand catheters. Alert 402 implies a "Map: magnetic distortion" when connected to CARTO 3 System. This issue may subsequently lead the physician to...
Cause as FDA categorized it: Under Investigation by firm · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-3178-2011 · Started Jul 7, 2011 · Posted by FDA Sep 12, 2011
Reason given: Biosense Webster has initiated a voluntary field notification to all customers that have a Stockert 70 Radio Frequency Generator, to communicate undetected software anomalies in the form of software release note in order to amend the labeling and thereby enhance the safety of the product.
Cause as FDA categorized it: Software design (manufacturing process) · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-1328-04 · Started Jul 16, 2004 · Posted by FDA Aug 7, 2004
Reason given: Generator Failure resulting increase of catheter temperature that could not be controlled by power reduction.
Cause as FDA categorized it: Other · Device type: Catheter, Electrode Recording, Or Probe, Electrode Recording (DRF)
Published research
The most relevant PubMed records for "Stockert 70 Radiofrequency"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code DRF.
- NavistarBiosense Webster, Inc. · PMA 2022
- Navi-Star Diagnostic/Ablation Deflectable Tip CatheterBiosense Webster, Inc. · PMA 2017
- Navistar Deflectable Tip Diagnostic/Ablation CatheterBiosense Webster, Inc. · PMA 2002
- Celsius Diagnostic/Ablation Deflectable Tip CatheterBiosense Webster, Inc. · PMA 2001
- Celsius/Celsius II Diagnostic/Ablation Deflectable Tip Catheters and Temperature CablesBiosense Webster, Inc. · PMA 2001
- nMARQ Catheter Interference CableBiosense Webster, Inc. · PMA 2024
- Biosense Webster CablesBiosense Webster, Inc. · PMA 2021
- Celsius Rmt Diagnostic/Ablation Deflectable Tip Catheters, Model D-1249-02-SBiosense Webster, Inc. · PMA 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.